IXICO Surpasses Sales Target for 2009-2010 Fiscal Year

Share Article

IXICO, Ltd., a global provider of clinical trial image management services and technologies, announced today that it has exceeded its annual sales target by twenty-five percent (25%), three months before the end of its fiscal year.

We're thrilled to announce that we've already exceeded our sales target for this fiscal year

IXICO, Ltd., a global provider of clinical trial image management services and technologies, announced today that it has exceeded its annual sales target by twenty-five percent (25%), three months before the end of its fiscal year.

The increase in IXICO's image management business is attributed to its expansion into new therapeutic areas and late phase trials based on a solid track record of performance on prior early phase trials. In addition, IXICO has seen a notable increase in Phase II and III awards in its core areas of strength in neurodegeneration and oncology.

"We're thrilled to announce that we've already exceeded our sales target for this fiscal year," notes Ciaran Cooper, Vice President of Business Development, "and we've still got three more months before our year end. We've built a solid foundation from which we're primed to grow our business over the next several years. Our key areas of focus are to continue growing our core strengths in oncology and neurodegeneration, most notably Alzheimer's disease, while we parlay our successes into new opportunities and market niches. In addition, we will continue to integrate into our services our enabling image management technologies, which provide tremendous value to our customers and make us stand out among our competitors. It's an exciting year."

IXICO's image management services are centered on the recognition that the most critical aspects of success lay in providing a seamless and comprehensive approach to the entire imaging trial spectrum, not solely the imaging core lab piece post-acquisition and pre-analysis. By design, IXICO has built its systems and workflows to address the critical areas of data acquisition, transfer, management, and analysis, including protocol optimization, site training, scanner QA, real-time data QC, and leading analysis methods. IXICO has developed a suite of enabling technology-based tools to help optimize this continuum, including its TrialWire™ electronic data transfer tool, its TrialTracker™ image management system, and its QCWizard™ semi-automated QC workflow.

About IXICO
IXICO, Ltd. is a full-service Imaging CRO that provides comprehensive, technology-based solutions for the pharmaceutical and biotech industries across all therapeutic areas and clinical trials phases. IXICO works within an ISO9001:2008 certified Quality Management System.

For more information please contact: Ciaran Cooper, VP Business Development at ciaran.cooper(at)ixico(dot)com
IXICO, Ltd. The London Bioscience Innovation Centre, 2 Royal College Street,
London NW1 0NH England - http://www.ixico.com
© 2010 IXICO, Ltd. All rights reserved

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Marketing IXICO
Visit website